• Collaboration unlocks multi-purpose capabilities to accelerate small molecule production
• Modular approach enables faster process transfer, sustainable operations, and fully integrated development solutions

Lisbon, Portugal, 24 September 2025 – Hovione, an international integrated pharmaceutical development and manufacturing organization, and Microinnova Engineering, a recognized leader in continuous process intensification, today announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry.
The companies will work together to test Microinnova’s modular manufacturing equipment in an industrial setting. The Microinnova equipment is designed to offer greater flexibility, easier scalability, enhanced efficiency and sustainable practices in active ingredient production. Together, the companies are aiming at faster process development, simple transition from lab to large-scale manufacturing, and ultimately decreased time to market for pharmaceutical customers.

"This collaboration with Microinnova underscores Hovione’s commitment to innovation in pharmaceutical manufacturing, with flow chemistry playing an important role in our long-term drug substance strategy,” said Dr. Jean-Luc Herbeaux, CEO of Hovione. “This partnership will allow us to shape and validate emerging continuous manufacturing technologies, which can potentially accelerate drug development and production.”

Dr. Dirk Kirschneck, Founder and Strategic Director at Microinnova. “This partnership reflects our shared vision to deliver modular manufacturing technologies that support pharmaceutical innovation and manufacturing excellence. We are proud to join forces with Hovione to showcase the capabilities of our next-generation modular equipment in a dynamic CDMO environment, demonstrating its versatility for multi-purpose manufacturing.”

About Hovione 
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) it has a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and manufacturing, capsule filling and devices. Hovione's culture is based on innovation, quality and dependability. Hovione is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards. For more information, please visit www.Hovione.com

About Microinnova
Microinnova provides process development as well as successful pilot plant & manufacturing plant solutions. Based on more than 20 years of experience in flow chemistry & process intensification and 250+ successfully completed projects, Microinnova is the partner of choice for continuous manufacturing.  Microinnova’s team uses process intensification techniques and selects the most advantageous technology for each process, even in regulated environments. As an ISO 9001:2015-certified company, Microinnova designs plants that meet GMP and ATEX standards for quality and safety. Specializing in modular continuous plants, Microinnova scales processes from lab tests to tons-per-hour production, enabling rapid time-to-market and flexibility. For more information, please visit microinnova.com